Inequitable Conduct Won't Undo Attorney-Client Privilege
The deceit Cephalon Inc. researcher and attorney allegedly used to obtain a patent for the drug Provigil didn't exempt communications between the drugmaker and its lawyers from attorney-client privilege, a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article